WuXi Biologics remains in Hang Seng ESG 50 Index after latest sustainability review
WuXi Biologics will remain in the Hang Seng ESG 50 Index. * It will also stay in the Hang Seng Corporate Sustainability Benchmark Index. The inclusions follow an A+ rating in the Hong Kong Quality Assurance Agency’s 2026 sustainability assessment. Disclaimer: This news brief was created by Public Technologies (PUBT) us